These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 15657223)

  • 1. Long term cardioprotective action of trimetazidine and potential effect on the inflammatory process in patients with ischaemic dilated cardiomyopathy.
    Di Napoli P; Taccardi AA; Barsotti A
    Heart; 2005 Feb; 91(2):161-5. PubMed ID: 15657223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trimetazidine and reduction in mortality and hospitalization in patients with ischemic dilated cardiomyopathy: a post hoc analysis of the Villa Pini d'Abruzzo Trimetazidine Trial.
    Di Napoli P; Di Giovanni P; Gaeta MA; Taccardi AA; Barsotti A
    J Cardiovasc Pharmacol; 2007 Nov; 50(5):585-9. PubMed ID: 18030070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of trimetazidine on cardiac function in diabetic patients with idiopathic dilated cardiomyopathy.
    Zhao P; Zhang J; Yin XG; Maharaj P; Narraindoo S; Cui LQ; Tang YS
    Life Sci; 2013 Mar; 92(11):633-8. PubMed ID: 22484413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of trimetazidine on quality of life in elderly patients with ischemic dilated cardiomyopathy.
    Marazzi G; Gebara O; Vitale C; Caminiti G; Wajngarten M; Volterrani M; Ramires JA; Rosano G; Fini M
    Adv Ther; 2009 Apr; 26(4):455-61. PubMed ID: 19396409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trimetazidine improves left ventricular function and quality of life in elderly patients with coronary artery disease.
    Vitale C; Wajngaten M; Sposato B; Gebara O; Rossini P; Fini M; Volterrani M; Rosano GM
    Eur Heart J; 2004 Oct; 25(20):1814-21. PubMed ID: 15474696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trimetazidine and the contractile response of dysfunctional myocardium in ischaemic cardiomyopathy.
    Belardinelli R
    Rev Port Cardiol; 2000 Nov; 19 Suppl 5():V35-9. PubMed ID: 11206102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of trimetazidine on the contractile response of chronically dysfunctional myocardium to low-dose dobutamine in ischaemic cardiomyopathy.
    Belardinelli R; Purcaro A
    Eur Heart J; 2001 Dec; 22(23):2164-70. PubMed ID: 11913478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic value of trimetazidine in patients with coronary heart disease and left ventricular dysfunction].
    Multicentral Collaborative Group on Trimetazidine (Phase IV)
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Sep; 33(9):793-5. PubMed ID: 16266453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of sustained-release trimetazidine on chronically dysfunctional myocardium of ischemic dilated cardiomyopathy - Six months follow-up result.
    Momen A; Ali M; Karmakar PK; Ali MZ; Haque A; Khan MR; Khalil MI; Hossain MS; Huda RM; Goni MN
    Indian Heart J; 2016; 68(6):809-815. PubMed ID: 27931552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trimetazidine administration minimizes myocardial damage and improves left ventricular function after percutaneous coronary intervention.
    Labrou A; Giannoglou G; Zioutas D; Fragakis N; Katsaris G; Louridas G
    Am J Cardiovasc Drugs; 2007; 7(2):143-50. PubMed ID: 17503885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of trimetazidine on left ventricular systolic function and physical tolerance in patients with ischaemic cardiomyopathy.
    Sisakian H; Torgomyan A; Barkhudaryan A
    Acta Cardiol; 2007 Oct; 62(5):493-9. PubMed ID: 17982971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure.
    Fragasso G; Palloshi A; Puccetti P; Silipigni C; Rossodivita A; Pala M; Calori G; Alfieri O; Margonato A
    J Am Coll Cardiol; 2006 Sep; 48(5):992-8. PubMed ID: 16949492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of trimetazidine combined with perindopril on NT-proBNP level in rats with dilated cardiomyopathy.
    Lin J; Zhong B; Yan J; Chen L
    Cell Mol Biol (Noisy-le-grand); 2020 May; 66(2):198-203. PubMed ID: 32415948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antianginal effects of trimetazidine and left ventricular function improvement in patients with stable angina pectoris.
    Shlyakhto EV; Almazov VV; Nifontov EM; Vakhrameyeva IV; Rudomanov OG; Zakharov DV; Kazarin VV; Vakhrameyeva NV
    Am J Cardiovasc Drugs; 2002; 2(2):119-24. PubMed ID: 14727987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A controlled study of the effects of carvedilol on clinical events, left ventricular function and proinflammatory cytokines levels in patients with dilated cardiomyopathy.
    Tatli E; Kurum T
    Can J Cardiol; 2005 Mar; 21(4):344-8. PubMed ID: 15838561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure.
    Fragasso G; Perseghin G; De Cobelli F; Esposito A; Palloshi A; Lattuada G; Scifo P; Calori G; Del Maschio A; Margonato A
    Eur Heart J; 2006 Apr; 27(8):942-8. PubMed ID: 16510466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trimetazidine, a metabolic modulator, has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathy.
    Tuunanen H; Engblom E; Naum A; Någren K; Scheinin M; Hesse B; Juhani Airaksinen KE; Nuutila P; Iozzo P; Ukkonen H; Opie LH; Knuuti J
    Circulation; 2008 Sep; 118(12):1250-8. PubMed ID: 18765391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effects of trimetazidine treatment on exercise tolerance and B-type natriuretic peptide and troponin T plasma levels in patients with stable ischemic cardiomyopathy.
    Di Napoli P; Di Giovanni P; Gaeta MA; D'Apolito G; Barsotti A
    Am Heart J; 2007 Sep; 154(3):602.e1-5. PubMed ID: 17719313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of trimetazidine in management of ischemic cardiomyopathy.
    Bertomeu-Gonzalez V; Bouzas-Mosquera A; Kaski JC
    Am J Cardiol; 2006 Sep; 98(5A):19J-24J. PubMed ID: 16931202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term beta-blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: a double-blind, randomized study of bucindolol versus placebo.
    Gilbert EM; Anderson JL; Deitchman D; Yanowitz FG; O'Connell JB; Renlund DG; Bartholomew M; Mealey PC; Larrabee P; Bristow MR
    Am J Med; 1990 Mar; 88(3):223-9. PubMed ID: 1968710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.